Krystal Biotech Inc (KRYS)
Days of inventory on hand (DOH)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 4.29 | 5.63 | 8.18 | 8.87 | 13.82 | 18.08 | 83.31 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DOH | days | 85.11 | 64.84 | 44.64 | 41.17 | 26.41 | 20.19 | 4.38 | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 4.29
= 85.11
The days of inventory on hand (DOH) for Krystal Biotech Inc have shown fluctuations over the past few years. The trend indicates that the company's inventory turnover has decreased from 4.38 days as of June 30, 2023, to 85.11 days as of December 31, 2024. This implies that it takes the company more days to sell its inventory, which could lead to higher carrying costs and potential obsolescence risks.
A higher DOH value suggests that Krystal Biotech Inc may be holding excess inventory or facing challenges in efficiently managing its inventory levels. This could impact the company's working capital requirements and overall profitability.
Further analysis is needed to understand the reasons behind the increasing days of inventory on hand and to mitigate any potential negative impacts on the company's financial performance and operations.
Peer comparison
Dec 31, 2024